- Home
- IMRN vs ADN Comparison
IMRN vs ADN Comparison
Compare IMRN & ADN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRN
- ADN
- Stock Information
- Founded
- IMRN 1994
- ADN 2006
- Country
- IMRN Australia
- ADN United States
- Employees
- IMRN N/A
- ADN N/A
- Industry
- IMRN Biotechnology: Pharmaceutical Preparations
- ADN Power Generation
- Sector
- IMRN Health Care
- ADN Utilities
- Exchange
- IMRN Nasdaq
- ADN Nasdaq
- Market Cap
- IMRN 10.1M
- ADN 16.7M
- IPO Year
- IMRN N/A
- ADN N/A
- Fundamental
- Price
- IMRN $1.80
- ADN $4.26
- Analyst Decision
- IMRN Strong Buy
- ADN
- Analyst Count
- IMRN 1
- ADN 0
- Target Price
- IMRN $5.00
- ADN N/A
- AVG Volume (30 Days)
- IMRN 3.2K
- ADN 16.2K
- Earning Date
- IMRN 03-25-2025
- ADN 12-27-2024
- Dividend Yield
- IMRN N/A
- ADN N/A
- EPS Growth
- IMRN N/A
- ADN N/A
- EPS
- IMRN N/A
- ADN N/A
- Revenue
- IMRN $4,048,286.00
- ADN $8,157,000.00
- Revenue This Year
- IMRN N/A
- ADN $2,232.99
- Revenue Next Year
- IMRN N/A
- ADN $91.56
- P/E Ratio
- IMRN N/A
- ADN N/A
- Revenue Growth
- IMRN 82.90
- ADN 274.35
- 52 Week Low
- IMRN $1.70
- ADN $1.71
- 52 Week High
- IMRN $3.09
- ADN $8.79
- Technical
- Relative Strength Index (RSI)
- IMRN 45.49
- ADN 41.73
- Support Level
- IMRN $1.75
- ADN $3.56
- Resistance Level
- IMRN $2.07
- ADN $5.11
- Average True Range (ATR)
- IMRN 0.11
- ADN 0.48
- MACD
- IMRN -0.01
- ADN -0.05
- Stochastic Oscillator
- IMRN 33.61
- ADN 44.83
About IMRN Immuron Limited
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
About ADN Advent Technologies Holdings Inc.
Advent Technologies Holdings Inc is an innovation-driven company in the fuel cell and hydrogen technology space. The company develops, manufactures, and assembles complete fuel cell systems and the critical components that determine the performance of hydrogen fuel cells and other energy systems. It serves automotive; aviation and power generation industries. It generates revenue from the sale of fuel cell systems and the sale of MEAs, membranes, and electrodes for specific applications in the fuel cell and energy storage (flow battery) markets.